Quantcast
Dynamic Duo Takes Out The Cellular Trash

Dynamic Duo Takes Out The Cellular Trash

Salk Institute Salk scientists identify how immune cells use two critical receptors to clear dead cells from the body, pointing the way to new autoimmune and cancer therapies. In most of the tissues of the body, specialized immune cells are...

Latest inflammation Stories

2014-09-17 08:28:52

Pivotal Phase 3 Clinical Trial Targeted to Begin in First Half of 2015 PRINCETON, N.J., Sept. 17, 2014 /PRNewswire/ -- Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that agreement has been reached with the US Food and Drug Administration (FDA) on the design of a pivotal, Phase 3 clinical trial evaluating its...

2014-09-11 12:27:04

SARASOTA, Fla., Sept. 11, 2014 /PRNewswire/ -- Lakewood-Amedex Inc., a leading developer of novel anti-infective pharmaceuticals, announced today that the United States Patent and Trademark Office has issued a 'Notice of Allowance' for patent application 11/673,486 entitled 'Oligonucleotide-Containing Pharmacological Compositions And Their Uses'. The '486 patent application relates to the Company's orally-deliverable nanoRNA therapeutics that act through gene-silencing and can be...

2014-09-09 08:31:27

MONMOUTH JUNCTION, N.J., Sept. 9, 2014 /PRNewswire/ -- CytoSorbents Corporation (OTCQB: CTSO), a blood purification company using its CytoSorb® extracorporeal cytokine adsorber to prevent or treat organ failure in life-threatening conditions, announced its U.S. Cardiac Surgery Advisory Board (CSAB) that includes leaders in cardiothoracic surgery, surgical critical care, extracorporeal therapy, and inflammation. The Board will oversee the use of CytoSorb® in cardiac surgery trials...

2014-09-05 08:23:11

Newly Acquired SGX301 Orphan Drug Candidate Being Evaluated for Treatment of Cutaneous T-Cell Lymphoma PRINCETON, N.J., Sept. 5, 2014 /PRNewswire/ -- Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today the acquisition of a novel orphan drug candidate, known as SGX301 (synthetic hypericin). SGX301 is poised to enter...

2014-08-28 23:06:07

September is National Pain Awareness Month. These are eight steps you can take to help prevent becoming one of the 100 million Americans who suffer from chronic pain. Marina del Rey & Newport Beach, CA (PRWEB) August 28, 2014 As September marks National Pain Awareness Month, vital focus returns to the more than 100 million people who suffer from chronic pain in America (Institute of Medicine Report from the Committee on Advancing Pain Research, Care, and Education). Chronic pain,...

fever origins
2014-08-28 03:00:29

David Engblom, Linköping University Fever is a response to inflammation, and is triggered by an onset of the signaling substance prostaglandin. Researchers at Linköping University can now see precisely where these substances are produced – a discovery that paves the way for smarter drugs. When you take an aspirin, all production of prostaglandins in the body is suppressed. All symptoms of inflammation are eased simultaneously, including fever, pain and loss of appetite. But it might...

2014-08-27 12:30:15

WASHINGTON, Aug. 27, 2014 /PRNewswire-USNewswire/ -- An experimental drug designed to help regulate the blood's iron supply shows promise as a viable first treatment for anemia of inflammation, according to results from the first human study of the treatment published online today in Blood, the Journal of the American Society of Hematology (ASH). Anemia is a condition that occurs when red blood cells are in short supply or do not function properly. When an individual has anemia,...

Scientists Find Control Signal For Immune System That Could Help Treat Autoimmune Diseases And Cancer
2014-08-18 03:19:20

Salk Institute When faced with pathogens, the immune system summons a swarm of cells made up of soldiers and peacekeepers. The peacekeeping cells tell the soldier cells to halt fighting when invaders are cleared. Without this cease-fire signal, the soldiers, known as killer T cells, continue their frenzied attack and turn on the body, causing inflammation and autoimmune disorders such as allergies, asthma, rheumatoid arthritis, multiple sclerosis and type 1 diabetes. Now, scientists at...

2014-08-09 23:03:01

101 Superfoods That Stop Your Joint Pain And Inflammation reviews have been flooding the Internet and HealthyandFitZone.com reveals the truth about this resource guide that promises to make known the many great tasting anti-inflammatory superfoods. Houston, TX (PRWEB) August 09, 2014 101 Superfoods That Stop Your Joint Pain And Inflammation is a resource guidebook that claims people will be able to enjoy delicious foods that heal their joints, protect their brain and feel energetic and...

2014-08-05 08:34:38

MORRISTOWN, N.J., Aug. 5, 2014 /PRNewswire/ -- Moerae Matrix, Inc. announced today the initiation of a Phase 1 clinical trial of MMI-0100, a first-in-class inhibitor of MAPKAP Kinase 2 (MK2) being developed for the treatment of idiopathic pulmonary fibrosis (IPF) and other diseases characterized by inflammation and fibrosis. The Phase 1 study is being conducted in the Netherlands and will evaluate the safety, tolerability and pharmacokinetics of ascending doses of MMI-0100 when given...


Word of the Day
malpais
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'